GOV.UK
Dodgy diet pills: Dying to lose weight?
MHRA launch FakeMeds campaign with warning on dodgy diet pills
Medicines & Healthcare products
Regulatory Agency
Freshers warned to be smart and avoid Modafinil
MHRA highlight the pitfalls of buying medicines online to students
Emergency contraceptive affected by other medicines - regulator issues new guidance
Women needing the emergency contraceptive pill containing levonorgestrel should tell their healthcare professional if they are currently taking...
MHRA and making a success of Brexit
The Agency's response to the outcome of the EU referendum.
E-cigarettes: regulations for consumer products
Preliminary guidance on how to get an e-cigarette on the market in the UK, including the notification scheme and reporting problems with...
Latest
-
Good laboratory practice (GLP) for safety tests on chemicals
- updated
- Guidance
-
Early access to medicines scheme applications: pending, refused, granted
- updated
- Official Statistics
-
Notify MHRA about a clinical investigation for a medical device
- updated
- Guidance
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health.
Documents
Our announcements
Our consultations
-
Pharmacy dispensing models and displaying prices on medicines
- Closed consultation
-
Regulatory fees for e-cigarettes
- Consultation outcome
Our publications
Our statistics
-
Early access to medicines scheme applications: pending, refused, granted
- Official Statistics
-
Pharmacovigilance inspection metrics, 2009 to present
- Official Statistics
Our management
-
Dr Ian Hudson
Chief Executive
-
Peter Commins
Chief Operating Officer
-
Dr Christian Schneider
Director of National Institute for Biological Standards and Control (NIBSC)
-
Dr Janet Valentine
Director of Clinical Practice Research Datalink (CPRD)
-
Dr Siu Ping Lam
Director of Licensing
-
Dr June Raine
Director of Vigilance and Risk Management of Medicines
-
Gerald Heddell
Director of Inspection, Enforcement and Standards
-
John Wilkinson
Director of Devices
-
John Quinn
Chief Information Officer
-
Rachel Bosworth
Director of Communications
-
Jonathan Mogford
Director of Policy
-
Vanessa Birchall-Scott
Director of Human Resources
Contact MHRA
General enquiries
151 Buckingham Palace Road
London
SW1W 9SZ
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
News centre
MHRA
151 Buckingham Palace Road
Victoria
London
SW1W 9SZ
Email newscentre@mhra.gsi.gov.uk
During office hours: 020 3080 7651 (08:30 - 17:00)
Out of office hours: 07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Accounts payable
Suppliers:
A to G – 0203 080 6766
H to O – 0203 080 6720
P to Z – 0203 080 6541
Accounts receivable
Email sales.invoices@mhra.gsi.gov.uk
Telephone 020 3080 6533
Case Referral Centre
151 Buckingham Palace Road
London
SW1W 9SZ
Email casereferrals@mhra.gsi.gov.uk
Telephone 0203 080 6330
Counterfeit reports
Counterfeit reports
151 Buckingham Palace Road
London
SW1W 9SZ
Email counterfeit@mhra.gsi.gov.uk
Telephone 0203 080 6701
Defective Medicines Reporting Centre (DMRC)
Email dmrc@mhra.gsi.gov.uk
Contact form https://www.gov.uk/rep...
DMRC (office hours) 020 3080 6574 (08.45 to 16.45 Monday to Friday)
DMRC (out of office hours) 07795 641532 (urgent calls outside of normal working hours, at weekends or on public holidays)
MHRA portal enquiries
Email manager.portal@mhra.gsi.gov.uk
Telephone 020 3080 7100
For enquiries about registering and submitting product licence applications using the MHRA portal.
Process licensing (PcL) enquiry line
5-Y
151 Buckingham Palace Road
London
SW1W 9SZ
Email pcl@mhra.gsi.gov.uk
Telephone 020 3080 6844
For enquiries from manufacturing and wholesale dealer licence holders, brokers and active substance manufacturers, importers and disitributors (and their representatives) about their licences.
Regulatory Information Service for Medicines (RIS) - clinical trials
Email RIS.CT@mhra.gsi.gov.uk
Regulatory Information Service for Medicines (RIS) 020 3080 7400
General or technical queries 020 3080 6456
Regulatory Information Service for Medicines (RIS) - new applications
Email RIS.NA@mhra.gsi.gov.uk
Regulatory Information Service 020 3080 7400
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request
- Check our previous releases to see if we’ve already answered your question
- Make a new request by contacting us at:
Corporate information
Jobs and contracts